Pidotimod

Pidotimod
Clinical data
Other names	(4R)-3-[(2S)-5-oxopyrrolidine-2-carbonyl]-1,3-thiazolidine-4-carboxylic acid
AHFS/Drugs.com	International Drug Names
ATC code	L03AX05 (WHO) ;
Identifiers
	IUPAC name (4R)-3-(5-oxo-L-prolyl)-1,3-thiazolidine-4-carboxylic acid;
PubChem CID	65944;
ChemSpider	59348 ;
UNII	785363R681;
KEGG	D07261 ;
ChEMBL	ChEMBL1488165 ;
CompTox Dashboard (EPA)	DTXSID0046199 ;
Chemical and physical data
Formula	C9H12N2O4S
Molar mass	244.26758 g/mol g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(O)[C@H]2N(C(=O)[C@H]1NC(=O)CC1)CSC2;
	InChI InChI=1S/C9H12N2O4S/c12-7-2-1-5(10-7)8(13)11-4-16-3-6(11)9(14)15/h5-6H,1-4H2,(H,10,12)(H,14,15)/t5-,6-/m0/s1 ; Key:UUTKICFRNVKFRG-WDSKDSINSA-N ;
	(what is this?) (verify)

Pidotimod is an immunostimulant.^[1]

References

^ Du XF, Jiang CZ, Wu CF, Won EK, Choung SY (September 2008). "Synergistic immunostimulating activity of pidotimod and red ginseng acidic polysaccharide against cyclophosphamide-induced immunosuppression". Archives of pharmacal research. 31 (9): 1153–9. doi:10.1007/s12272-001-1282-6. PMID 18806958.{{cite journal}}: CS1 maint: multiple names: authors list (link)

This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.